PBMWW PSYENCE BIOMEDICAL LTD.
Price Chart
Executive Summary
Psyence Biomedical filed an amended equity incentive plan (6-K) to correct a typographical error in Section 4(b) of its 2023 Equity Incentive Plan. The filing is a routine administrative amendment with no material financial impact.
Actionable Insight
No trading action warranted. This is a routine clerical correction with zero economic impact. Monitor future filings for actual equity grants under the plan.
Key Facts
- On May 4, 2026, the Board approved an amendment to correct a typographical error in Section 4(b) of the existing 2023 Equity Incentive Plan.
- The Plan Share Limit remains unchanged at 13,635 post-share consolidation shares (8,150,126 pre-consolidation).
- No new share grants, dilution, or changes to outstanding awards are described in this filing.
Financial Impact
No financial impact — the amendment is purely administrative (correcting a typo) with no change to share count, dilution, or economics.
Market Snapshot
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001213900-26-065824 |
| Document: ea0293772-6k_psyence.htm | 0001213900-26-065824 |
| Document: 0001213900-26-065824-index-headers.html | 0001213900-26-065824 |
| Document: 0001213900-26-065824-index.html | 0001213900-26-065824 |
| Document: 0001213900-26-065824.txt | 0001213900-26-065824 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 5, 2026
7d ago
|
6-K
| $0.0200 awaiting T+20 | awaiting T+20 | — | $0.0200 (−0.00%) |
|
Apr 23, 2026
7w ago
|
6-K
| $0.0200 $0.0200 | · 0.00% | ▼ −4.03% | $0.0200 (−0.00%) |
|
Apr 20, 2026
7w ago
|
6-K
| $0.0200 $0.0200 | · 0.00% | ▲ +4.20% | $0.0200 (+0.00%) |
|
Apr 17, 2026
8w ago
|
6-K
| $0.0200 $0.0200 | · 0.00% | ▼ −4.20% | $0.0200 (−0.00%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access